Bronchiolitis obliterans is a rare, serious lung condition in which the smallest airways, called bronchioles, become scarred and permanently narrowed. The result is irreversible airflow obstruction that can range from mild breathlessness to severe respiratory failure. It shows up in several very different settings, from organ transplant recipients and factory workers to children recovering from a bad respiratory infection, and the scarring it causes does not respond well to most standard treatments.
What Happens Inside the Airways
The bronchioles are tiny tubes, just a millimeter or two across, that deliver air to the deepest parts of the lungs. In bronchiolitis obliterans, something triggers damage to the lining of those tubes. The body’s repair process then overshoots, laying down scar tissue that narrows or completely blocks the airway from the inside. The surrounding lung tissue is usually spared, which is part of what makes the disease tricky to detect on ordinary imaging.
Researchers have described two main patterns of that scarring. In one form, called constrictive bronchiolitis obliterans, a ring of scar tissue builds up beneath the airway lining and squeezes the tube shut concentrically. In the other, sometimes called cellular or destructive bronchiolitis obliterans, inflammatory cells and granulation tissue fill the airway lumen directly, while also invading the airway wall and the tissue surrounding it.1PubMed. Histopathological bronchial reconstruction of human bronchiolitis obliterans Both roads lead to the same destination: permanently obstructed small airways and reduced airflow that does not improve with bronchodilators.
After a Lung Transplant
The most well-known context for bronchiolitis obliterans is lung transplantation, where it is the single biggest threat to long-term survival. Most transplant centers track it under the clinical label “bronchiolitis obliterans syndrome” (BOS), which is diagnosed by a sustained drop in lung function rather than by biopsy. BOS is the most common form of chronic lung allograft dysfunction and remains the major barrier to keeping transplanted lungs working over the years.2PubMed Central. Bronchiolitis obliterans syndrome: the Achilles’ heel of lung transplantation In BOS, small airways are choked by chronic inflammation and fibrosis while the rest of the lung parenchyma stays relatively intact.3PubMed Central. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation
The numbers are sobering. BOS affects roughly half to three-fifths of patients who survive five years after surgery, and it accounts for more than 30 percent of all deaths occurring after the third year post-transplant. Five-year survival after the onset of BOS is only about 30 to 40 percent.4European Respiratory Journal. Post-transplant bronchiolitis obliterans
Several risk factors accelerate its appearance. In one analysis, cytomegalovirus pneumonia roughly tripled the risk, mismatches in certain immune markers between donor and recipient doubled it, and episodes of acute rejection occurring later in the post-transplant course also predicted earlier BOS onset.5PubMed. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation This is part of the reason transplant teams invest heavily in preventing infections and fine-tuning immunosuppression after the operation.
After a Stem Cell Transplant
Lung transplant recipients are not the only transplant patients at risk. Bronchiolitis obliterans also develops in people who have received an allogeneic hematopoietic stem cell transplant, the procedure sometimes called a bone marrow transplant. In this setting, it is understood as a form of chronic graft-versus-host disease, where donor immune cells attack the recipient’s tissues, in this case the small airways.6PubMed Central. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation It typically shows up as moderate to severe airflow obstruction months after the transplant.7Respiratory Medicine Case Reports. Early and rapid development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation
Because the driving force here is immune attack rather than inhaled toxins or infection, treatment strategies lean heavily on immune-modulating drugs rather than anti-inflammatory agents alone. The prognosis in this population is similarly poor, and many patients face a relentless decline in lung function even with aggressive therapy.
The Popcorn Lung Story
In the early 2000s, an investigation at a microwave-popcorn factory in Missouri turned bronchiolitis obliterans into a public health headline. Workers who mixed butter-flavoring chemicals were developing fixed airflow obstruction at alarming rates. The New England Journal of Medicine published findings linking the disease to inhalation of volatile flavoring ingredients, especially a chemical called diacetyl.8PubMed. Clinical Bronchiolitis Obliterans in Workers at a Microwave-Popcorn Plant The nickname “popcorn lung” stuck.
Subsequent studies confirmed that diacetyl was not just a hazard in the food-production lines that used it as an ingredient. Chemical workers who manufactured diacetyl itself also developed bronchiolitis obliterans at rates consistent with the downstream factory outbreaks.9American Journal of Respiratory and Critical Care Medicine. Bronchiolitis Obliterans Syndrome in Chemical Workers Producing Diacetyl for Food Flavorings After the initial outbreaks led to engineering controls and ventilation upgrades at affected plants, follow-up research showed that exposure levels dropped, but lung disease risk did not disappear entirely, suggesting that even lower concentrations could still cause harm over time.10PubMed Central. Occupational lung disease risk and exposure to butter-flavoring chemicals after implementation of controls at a microwave popcorn plant
One detail that often gets overlooked: when the food industry reformulated products to replace diacetyl, it sometimes turned to 2,3-pentanedione, a structurally similar chemical. Animal studies indicate that this substitute carries comparable respiratory toxicity, and other related chemicals in the same family have not been evaluated for safety at all.11Clinical Pulmonary Medicine. Respiratory Disease Among Flavoring-exposed Workers in Food and Flavoring Manufacture The occupational risk, in other words, did not vanish when diacetyl was pulled from some products.
Vaping and E-Cigarettes
The same flavoring chemicals that caused disease in factory workers also appear in some e-cigarette liquids, which is why vaping and bronchiolitis obliterans keep getting linked in headlines. Diacetyl and similar compounds have been detected in flavored vaping products, and at least one case report described a young Canadian patient whose clinical picture was suggestive of bronchiolitis obliterans secondary to inhaling flavoring agents in e-liquids, though the exact mechanism and causative agent could not be pinpointed.12PubMed Central. Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth
A case series published in NEJM Evidence went further, identifying a pattern of small-airway fibrosis including constrictive bronchiolitis in vaping patients. After ruling out other causes, the investigators considered e-cigarette use the most likely explanation, noting that symptoms partially improved once the patients stopped vaping.13PubMed Central. E-Cigarette Use, Small Airway Fibrosis, and Constrictive Bronchiolitis The evidence is still building. Researchers have started using single-cell sequencing to examine how human airway cells respond to diacetyl and other bronchiolitis-obliterans-associated chemicals at the molecular level, trying to fill in the gap between the exposure and the scarring.14PubMed Central. Single-cell resolution of human airway epithelial cells exposed to bronchiolitis obliterans-associated chemicals For now, the honest take is that vaping can plausibly cause this type of airway damage, but definitive proof in the form of large population studies has not arrived yet.
Military Burn Pits and Toxic Inhalation
A study of U.S. soldiers returning from Iraq and Afghanistan revealed another route to bronchiolitis obliterans: battlefield inhalation exposures. Among 49 soldiers with unexplained exercise intolerance who underwent open lung biopsy, constrictive bronchiolitis was the finding. Twenty-eight of them had served in northern Iraq in 2003 and reported breathing smoke from a sulfur-mine fire near Mosul, where sulfur dioxide concentrations reached extremely high levels. Others reported exposure to dust storms, open-air burn pits used for waste disposal, or incinerated human waste.15PubMed Central. Constrictive Bronchiolitis in Soldiers Returning from Iraq and Afghanistan Eleven of the soldiers, however, could not identify any single dramatic exposure, raising the possibility that chronic lower-level inhalation of particulate matter and combustion byproducts was sufficient.
Understanding of inhalational constrictive bronchiolitis has evolved over time as new exposure scenarios have come to light, and military burn-pit exposure in particular has become an ongoing area of public health concern and veterans’ advocacy.16PubMed. Inhalational Constrictive Bronchiolitis: The Evolution of our Understanding of this Disease
Post-Infectious Bronchiolitis Obliterans in Children
In children, the most common trigger is a severe lower respiratory tract infection. Post-infectious bronchiolitis obliterans, sometimes abbreviated PIBO, develops after the initial infection clears but the airway damage keeps progressing. Adenovirus is the pathogen most frequently involved worldwide, with Mycoplasma pneumoniae also playing a significant role, especially in certain regions.17PubMed Central. Pathogenesis and Risk Factors of Post-Infectious Bronchiolitis Obliterans in Children Both organisms trigger intense inflammation in the small airways, and the immune response to them converges on similar pathways that ultimately produce fibrotic narrowing of the bronchioles.
Risk factors in children include being male, needing mechanical ventilation during the initial infection, and having low blood oxygen levels at the time of diagnosis.18PubMed. Post viral bronchiolitis obliterans in children: A rare and potentially devastating disease The clinical spectrum is broad. Some children end up with mild, fixed airflow limitation they can live with; others need continuous supplemental oxygen. A definitive diagnosis often requires lung biopsy, which is invasive and not ideal for catching the disease early.19PubMed Central. Postinfectious Bronchiolitis Obliterans in Children
Long-term follow-up data show that children with PIBO carry severely impaired lung function for years. In one cohort followed for about twelve years, the obstructive pattern with air trapping improved slowly during childhood but never resolved.20Thorax. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up These children essentially grow up with fixed airway disease.
Autoimmune Connections
Outside of transplant and infection, rheumatoid arthritis is the condition most commonly linked to bronchiolitis obliterans. Among the connective tissue diseases, rheumatoid arthritis dominates the case reports, though bronchiolitis obliterans has also been seen in Sjögren syndrome and, very rarely, systemic sclerosis.21European Respiratory Journal. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis Most cases develop within the first five years of arthritis being diagnosed, but in roughly one in five patients, the airway disease is actually the first clue that rheumatoid arthritis exists at all.
Outside of organ transplantation, connective tissue diseases are the most frequent association.22PubMed Central. Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series This matters because a patient showing up with progressive, unexplained airflow obstruction and no transplant or chemical exposure history should probably be screened for autoimmune disease.
How It Gets Diagnosed
One of the frustrations with bronchiolitis obliterans is that it can masquerade as asthma or COPD, particularly in non-transplant patients.23PubMed. Bronchiolitis obliterans Standard chest X-rays are usually normal or show only subtle changes. The scarring happens in airways too small to see on plain film.
High-resolution CT scanning is far more useful. The hallmark finding is a mosaic pattern of patchy areas where the lung looks darker than normal, representing trapped air or reduced blood flow in lobules where the small airways are blocked.24Journal of Computer Assisted Tomography. Bronchiolitis obliterans on high-resolution ct: A pattern of mosaic oligemia Scanning during expiration amplifies this finding. In one study of lung transplant recipients, air trapping on expiratory CT had a sensitivity above 90 percent and an accuracy of 86 percent for detecting the disease.25PubMed. Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT
In transplant patients, serial breathing tests that show a progressive drop in airflow are usually enough to make the clinical diagnosis of BOS without a biopsy. In non-transplant settings, where the diagnosis is less expected, an open lung biopsy is often needed to confirm what is going on. There is also interest in blood biomarkers: serum levels of a protein called KL-6 are elevated in lung transplant recipients with BOS and correlate with the degree of lung-function decline, offering potentially better diagnostic accuracy than bronchoalveolar lavage alone.26PubMed. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation
Distinguishing bronchiolitis obliterans from severe asthma in younger patients can be especially difficult. Both conditions cause airflow obstruction, and both can look abnormal on CT. Research comparing adolescents and young adults with the two diagnoses found that bronchiolitis obliterans patients had more severe obstruction, more hyperinflation, and more prominent mosaic pattern and air trapping on imaging. Asthma patients, meanwhile, were more likely to have allergic sensitization. A combination of lung function variables, CT findings, and allergy markers could reliably separate the two.27PubMed. Clinical, radiological, and physiological differences between obliterative bronchiolitis and problematic severe asthma in adolescents and young adults
Treatment Options and Their Limits
Treating bronchiolitis obliterans has historically been described, bluntly, as disappointing. Systemic corticosteroids and augmented immunosuppression produce inconsistent results, and for lung transplant patients with progressive BOS, re-transplantation has sometimes been the only remaining option.28PubMed. Bronchiolitis obliterans But the therapeutic landscape has shifted somewhat in recent years.
The antibiotic azithromycin, used here for its anti-inflammatory properties rather than its germ-killing ability, has become a first-line treatment for BOS after lung transplantation. A randomized controlled trial showed that azithromycin improved lung function in a meaningful proportion of patients, though not all responded.29Thorax. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation The mechanism seems to involve tamping down airway inflammation: azithromycin markedly reduces the percentage of inflammatory white blood cells in the airways and lowers levels of the signaling molecule that recruits them.30American Journal of Respiratory and Critical Care Medicine. Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans Syndrome
For stem cell transplant patients with BOS, newer drug combinations are being explored. Pirfenidone, an anti-fibrotic medication originally developed for a different form of lung scarring, showed promise in a trial where about 40 percent of participants had stabilization or improvement in lung function over twelve months.31PubMed Central. Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease A salvage regimen combining low-dose ruxolitinib (a drug that blocks inflammatory signaling) with nintedanib (another anti-fibrotic) produced an overall response rate above 60 percent in patients whose BOS had failed to respond to standard immunosuppressive therapy, compared to about 14 percent in the control group.32PubMed Central. Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation
Even more recently, a first-line strategy combining low-dose ruxolitinib with pirfenidone and reduced-dose calcineurin inhibitors was tested in a small group of BOS patients. After three months, half achieved complete remission and lung function improved in 85 percent of participants.33Blood. First-line treatment with low-dose ruxolitinib, pirfenidone, and low-dose calcineurin inhibitors leads to significant improvement in patients with bronchiolitis obliterans syndrome after allogeneic transplantation These are small, early-phase studies, and results need confirmation in larger trials. But for a disease that was long considered essentially untreatable, the trajectory is cautiously encouraging.
The Role of Pulmonary Rehabilitation
Drugs aside, pulmonary rehabilitation is one of the few interventions that reliably helps patients feel and function better. In a study of BOS patients after stem cell transplant who completed a structured rehab program, every patient improved their six-minute walk distance, and those who filled out quality-of-life questionnaires showed a meaningful gain in physical functioning.34PubMed Central. Pulmonary Rehabilitation for Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation A separate case series confirmed that comprehensive pulmonary rehabilitation can improve exercise tolerance and breathlessness in BOS patients more broadly.35PubMed Central. Comprehensive pulmonary rehabilitation in patients with bronchiolitis obliterans syndrome: A case series
Pulmonary rehabilitation does not reverse the scarring. It works by training the muscles and the cardiovascular system to extract more from whatever lung capacity remains. For patients with limited pharmaceutical options, that can mean the difference between being housebound and being able to walk around a neighborhood. It remains underutilized, partly because the disease is rare enough that many rehab programs have little experience with it.
The Molecular Machinery Behind the Scarring
At the cellular level, the scarring in bronchiolitis obliterans is driven by cells called myofibroblasts, which are essentially fibroblasts that have shifted into a wound-healing overdrive mode. A growth factor called TGF-β pushes fibroblasts to transform into these scar-producing cells. Research in animal models showed that one specific signaling molecule within the TGF-β pathway, Smad3, plays a key role. Fibroblasts lacking Smad3 produced far less of the contractile protein that characterizes myofibroblasts, though TGF-β could still partially activate scar production through backup signaling routes.36American Journal of Transplantation. Myofibroblast Transdifferentiation in Obliterative Bronchiolitis: TGF-β Signaling Through Smad3-Dependent and -Independent Pathways This redundancy helps explain why blocking just one arm of the fibrotic process has not been enough to cure the disease. It also points drug developers toward multi-target strategies, which is exactly the direction the newest combination therapies are heading.